Effect of overnight nasal continuous positive airway pressure treatment on the endothelial function in patients with obstructive sleep apnea;Obstrüktif uyku apnesi olan hastalarda bir gecelik nazal sürekli pozitif hava yolu basıncı tedavisinin endotel fonksiyonuna etkisi

Anadolu Kardiyoloji Dergisi

Volumn 12, Issue 7, 2012, Pages 560-565

  Tulmaç, Murat ^a   Tireli, Emine ^c   Ebinç, Haksun ^a   Şimşek, Vedat ^a   Doǧru, Mehmet Tolga ^a   Yildirim, Nesligül ^a   Kisa, Üçler ^a   Ekici, Mehmet Savaş ^b  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

^c Kahramanmaras State Hospital   (Turkey)

Author keywords

C reactive protein; Continuous positive airway pressure; Endothelial dysfunction; Flow mediated dilatation; Obstructive sleep apnea

Indexed keywords

C REACTIVE PROTEIN; OXYGEN;

ADULT; AGED; BLOOD; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CLINICAL TRIAL; ECHOGRAPHY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PROSPECTIVE STUDY; SLEEP APNEA, OBSTRUCTIVE; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; AGED; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CONTINUOUS POSITIVE AIRWAY PRESSURE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYGEN; PROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE; VASODILATION;

EID: 84868271385     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2012.181     Document Type: Article

References (32)

1. Drager LF, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 2011;140:534-542. [CrossRef]
2. Peker Y, Hedner J, Kraiczi H, Loth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000;162:81-86.
3. Celen YT, Peker Y. Cardiovascular consequences of sleep apnea: I-epidemiology. Anadolu Kardiyol Derg 2010;10:75-80. [CrossRef]
4. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002;166:159-165. [CrossRef]
5. Milleron O, Pilliere R, Foucher A, de Roquefeuil F, Aegerter P, Jondeau G, et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004;25:728-734. [CrossRef]
6. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-1053. [CrossRef]
7. Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a metaanalysis. Arch Intern Med 2003;163:565-571. [CrossRef]
8. Ryan S, Taylor CT, McNicholas WT. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 2009;64:631-636.
9. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 2008;52:686-617. [CrossRef]
10. Widlansky ME, Gökçe N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003;42:1149-1160. [CrossRef]
11. Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol 1999;34:631-638. [CrossRef]
12. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007;176:706-712. [CrossRef]
13. Bayram NA, Çiftci B, Keleş T, Durmaz T, Turhan S, Bozkurt E, et al. Endothelial function in normotensive men with obstructive sleep apnea before and 6 months after CPAP treatment. Sleep 2009;32:1257-1263.
14. Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004;169:348-353. [CrossRef]
15. Lattimore JL, Wilcox I, Skilton M, Langenfeld M, Celermajer DS. Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 2006;61:491-495. [CrossRef]
16. Ohike Y, Kozaki K, Iijima K, Eto M, Kojima T, Ohga E, et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure--possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 2005;69:221-226. [CrossRef]
17. Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lucke C, Mayer K, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000;55:1046-1051. [CrossRef]
18. Jelic S, Lederer DJ, Adams T, Padeletti M, Colombo PC, Factor P, et al. Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea. Vasc Health Risk Manag 2009;5:909-920. [CrossRef]
19. El Solh AA, Akinnusi ME, Baddoura FH, Mankowski CR. Endothelial cell apoptosis in obstructive sleep apnea: a link to endothelial dysfunction. Am J Respir Crit Care Med 2007;175:1186-1191. [CrossRef]
20. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O, et al. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J 1995;74:247-253. [CrossRef]
21. Turgut Çelen Y, Peker Y. Cardiovascular consequences of sleep apnea: II-Cardiovascular mechanisms. Anadolu Kardiyol Derg 2010;10:168-175. [CrossRef]
22. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129-1134. [CrossRef]
23. Coutinho T, Goel K, Correa de Sa D, Kragelund C, Kanaya AM, Zeller M, et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol 2011;57:1877-1886. [CrossRef]
24. Bonsignore MR, Parati G, Insalaco G, Castiglioni P, Marrone O, Romano S, et al. Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP. Eur Respir J 2006;27:128-135. [CrossRef]
25. Gilman MP, Floras JS, Usui K, Kaneko Y, Leung RS, Bradley TD. Continuous positive airway pressure increases heart rate variability in heart failure patients with obstructive sleep apnoea. Clin Sci (Lond) 2008;114:243-249. [CrossRef]
26. Özeke O, Güngör M, Hizel SB, Aydin D, Ertürk O, Çelenk MK, et al. Influence of the severity of obstructive sleep apnea on nocturnal heart rate indices and its association with hypertension. Anadolu Kardiyol Derg 2011;11:509-514.
27. Tanriverdi H, Evrengül H, Kara CO, Kuru O, Tanriverdi S, Özkurt S, et al. Aortic stiffness, flow-mediated dilatation and carotid intimamedia thickness in obstructive sleep apnea: non-invasive indicators of atherosclerosis. Respiration 2006;73:741-750. [CrossRef]
28. Chung S, Yoon IY, Shin YK, Lee CH, Kim JW, Ahn HJ. Endothelial dysfunction and inflammatory reactions of elderly and middle-aged men with obstructive sleep apnea syndrome. Sleep Breath 2009;13:11-17. [CrossRef]
29. Oflaz H, Çuhadaroǧlu C, Pamukçu B, Meriç M, Ece T, Kaşikcioǧlu E, et al. Endothelial function in patients with obstructive sleep apnea syndrome but without hypertension. Respiration 2006;73:751-756. [CrossRef]
30. Wang ZF, Feng XW, Kang J. [Endothelium-dependent vasodilation in patients with obstructive sleep apnea-hypopnea syndrome]. Zhonghua Jie He He Hu Xi Za Zhi 2006;29:744-746.
31. Witte DR, Westerink J, de Koning EJ, van der Graaf Y, Grobbee DE, Bots ML. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? J Am Coll Cardiol 2005;45:1987-1993. [CrossRef]
32. Kao PC, Shiesh SC, Wu TJ. Serum C-reactive protein as a marker for wellness assessment. Ann Clin Lab Sci 2006,36:163-169.